– OncoVerity licenses Cusatuzumab, a first-in-class anti-CD70 antibody, from argenx – Max Colao, MBA appointed as Chief Executive Officer and Dr. Clay Smith as Chief Medical Officer – OncoVerity closes $30M Series A financing AURORA, Colo.–(BUSINESS WIRE)–OncoVerity, a pioneer in applying advanced multiomic, data driven patient stratification to the development of human therapeutics in oncology, … [Read more…]

Company seeks 20 instructors teaching Introduction to Psychology and 20 teaching Introduction to Biology from minority serving institutions NEW YORK–(BUSINESS WIRE)–#edchat–Macmillan Learning, a privately-held, family-owned education publishing and service company, is seeking instructors teaching Introduction to Psychology or Introduction to Biology this fall to participate in research on closing equity gaps through evidence-based teaching practices. … [Read more…]

The event will be held on Tuesday, March 28, from 10 AM to 1 PM CT. AMARILLO, Texas & ATLANTA–(BUSINESS WIRE)–Allington Dental & Braces, a Benevis-supported dental practice, is pleased to announce the addition of two new clinicians to their team – Dr. Chase Thorpe, DMD, and Dr. Lauren Hodges, DDS. With a commitment to … [Read more…]

MaaT Pharma received authorizations from French and German regulatory authorities to initiate its Phase 2b clinical trial evaluating MaaT033 in improving survival in patients receiving allogeneic hematopoietic stem-cell transplantation (allo-HSCT) MaaT Pharma also received regulatory authorization in France to initiate a Phase 1b pilot study to evaluate MaaT033 in amyotrophic lateral sclerosis (ALS) LYON, France–(BUSINESS … [Read more…]

LYON, France–(BUSINESS WIRE)–The French Blood Establishment (EFS) and Brenus Pharma announce their strategic partnership in the bioproduction of innovative therapy drugs (ITD), highlighting French expertise. This collaboration is part of a shared vision: developing the French bioproduction sector nationally and internationally. EFS’ Cell Therapy and Engineering Unit (UTICELL), based in Saint-Ismier, France, shows recognized expertise … [Read more…]

National Omnichannel Media Network Focused on Helping People Overcome Poverty Brian Jones Appointed Senior Vice President and General Manager NEWTOWN SQUARE, Pa.–(BUSINESS WIRE)–#AmeriHealthCaritas—AmeriHealth Caritas, a national leader in Medicaid managed care and other health care solutions for those most in need, announced the launch of a national media network to spotlight, amplify and support solutions … [Read more…]

TOLEDO, Ohio & ANTWERP, Belgium–(BUSINESS WIRE)–#CRO—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of SUAZIO, an EU-based strategic consultancy providing global market research services to medical device and IVD developers. Founded in 2001 in Antwerp, Belgium, SUAZIO’s mission is to provide market insights to the MedTech … [Read more…]

Five new models are now up to 83%1 more powerful, as well as quieter and smarter CHICAGO–(BUSINESS WIRE)–Blueair, a global leader in indoor air purification solutions, announced today the launch of its Blue Pure Max line of air purifiers. Building on the award-winning Blue Pure Auto family of air purifiers, the new models feature enhanced … [Read more…]

SpermX™ delivers reliable results to solve sexual assault crimes NEW ORLEANS–(BUSINESS WIRE)–Addressing a long-term shortcoming in DNA evidence for rape and sexual assault cases, New Orleans-based InnoGenomics has developed a nanotech method, SpermX™ that drastically increases usable results to solve more crimes. The novel nanotechnology-derived polymer outperforms conventional methods, capturing male DNA from as few … [Read more…]

Data presented at plenary session of Society of Gynecologic Oncology Meeting  Patients treated suffered from platinum resistant/refractory ovarian cancer Previous PD-(L)1/CTLA-4  combinations have reported only 3-10% responses in comparable patient populations1,2 Findings consistent with botensilimab/balstilimab benefit in cold and refractory tumors across 9 different solid tumor cancers LEXINGTON, Mass.–(BUSINESS WIRE)–Agenus Inc. (Nasdaq: AGEN), an immuno-oncology … [Read more…]